Jopari AttachInsights and Jopari RiskReview extend company’s end-to-end claims processing platform CONCORD, Calif.–(BUSINESS WIRE)–Jopari Solutions, a leader inJopari AttachInsights and Jopari RiskReview extend company’s end-to-end claims processing platform CONCORD, Calif.–(BUSINESS WIRE)–Jopari Solutions, a leader in

Jopari Launches New Solutions to Improve Early Claim Severity Identification and Automated Clinical Data Extraction

Jopari AttachInsights and Jopari RiskReview extend company’s end-to-end claims processing platform

CONCORD, Calif.–(BUSINESS WIRE)–Jopari Solutions, a leader in straight-through electronic claims processing for Property & Casualty (P&C), Commercial and Government healthcare, today announced the addition of two new product offerings – Jopari AttachInsights and Jopari RiskReview – to its established portfolio of electronic billing, attachment and payment solutions.

Claims organizations face growing pressure to manage rising complexity, higher volumes, and increased cost scrutiny. Jopari’s new solutions add structured, actionable intelligence to the early stages of the claims lifecycle—supporting more consistent, informed decision-making from intake through adjudication.

“Since Jopari’s beginning over two decades ago, we have eliminated fragmented billing, mailroom processing, and manual intervention for our clients, ultimately reducing operational costs,” said Founder and CEO Steve Stevens. “While our core product portfolio has served our clients well, claims organizations are under immense pressure to do more with less. We must evolve alongside our clients to continually drive outcomes.”

To accomplish this, Jopari is applying artificial intelligence with the introduction of Jopari AttachInsights – an automated clinical data extraction and normalization solution — and Jopari RiskReview, a predictive claim severity scoring tool designed to identify high-risk claims earlier in the lifecycle. Together, these solutions help claims organizations prioritize work, reduce manual clinical review effort, and accelerate resolution of complex claims.

Both solutions integrate seamlessly with Jopari’s existing platform, allowing payers to utilize a single system for claims intake, clinical insight, billing, attachments, and payment workflow.

“With more than three million claims flowing through Jopari every month, AttachInsights and RiskReview unlock intelligence at scale—empowering claims and clinical teams to intervene earlier, gain clearer insight into medical complexity, and make more informed decisions that ultimately drive better outcomes for claimants,” said Chief Growth Officer Jeff Pirino.

To learn more about Jopari’s full suite of solutions, please visit jopari.com.

Jopari Solutions is a healthcare technology leader transforming the Property & Casualty, Auto, Commercial, and Government Health markets through a payer-agnostic claims and payments network that automates the entire healthcare claims lifecycle. Leveraging intelligent automation, compliance expertise, and a vast provider-payer network, Jopari enables organizations to achieve straight-through electronic processing with greater efficiency, visibility, and security.

For more information, visit www.jopari.com.

Contacts

Media Contact:
Jeff Pirino

Chief Growth Officer

Jopari Solutions

925-459-5253

Market Opportunity
PoP Planet Logo
PoP Planet Price(P)
$0.0163
$0.0163$0.0163
-0.18%
USD
PoP Planet (P) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.